IFP Advisors, Inc - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 254 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$11,436
+530.1%
1,340
+168.0%
0.00%
Q1 2023$1,815
+15025.0%
500
-75.3%
0.00%
Q4 2022$12
-99.9%
2,023
-15.7%
0.00%
Q3 2022$9,0000.0%2,3990.0%0.00%
Q2 2022$9,0000.0%2,3990.0%0.00%
Q1 2022$9,0002,3990.00%
Q2 2021$000.00%
Q1 2021$000.00%
Q4 2020$000.00%
Q3 2020$000.00%
Q2 2020$000.00%
Q1 2020$000.00%
Q4 2019$0
-100.0%
0
-100.0%
0.00%
Q3 2019$7,000
+133.3%
1,324
+32.4%
0.00%
Q3 2017$3,0000.0%1,0000.0%0.00%
Q2 2017$3,000
+50.0%
1,0000.0%0.00%
Q1 2017$2,000
+100.0%
1,0000.0%0.00%
Q4 2016$1,0000.0%1,0000.0%0.00%
Q3 2016$1,0000.0%1,0000.0%0.00%
Q2 2016$1,0001,0000.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 589,883$590,0001.38%
Broadfin Capital, LLC 8,200,000$8,610,0000.96%
Avoro Capital Advisors LLC 1,141,149$1,198,0000.24%
CORRADO ADVISORS, LLC 190,600$200,0000.12%
Baker Brothers Advisors 5,102,153$5,357,0000.05%
KINGDON CAPITAL MANAGEMENT, L.L.C. 756,311$794,0000.04%
Point72 Asset Management, L.P. 2,272,816$2,386,0000.02%
AGRAN LIBBIE 44,000$46,0000.01%
COMPTON CAPITAL MANAGEMENT INC /RI 10,000$11,0000.01%
KENNEDY CAPITAL MANAGEMENT LLC 233,171$245,0000.00%
View complete list of CATALYST PHARMACEUTICALS INC shareholders